Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC–MS/MS

Min Yuan, Daniel M. Kremer, He Huang, Susanne B. Breitkopf, Issam Ben-Sahra, Brendan D. Manning, Costas A. Lyssiotis, John M. Asara*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Abstract

Targeted tandem mass spectrometry (LC–MS/MS) has been extremely useful for profiling small molecules extracted from biological sources, such as cells, bodily fluids and tissues. Here, we present a protocol for analysing incorporation of the non-radioactive stable isotopes carbon-13 ( 13 C) and nitrogen-15 ( 15 N) into polar metabolites in central carbon metabolism and related pathways. Our platform utilizes selected reaction monitoring (SRM) with polarity switching and amide hydrophilic interaction liquid chromatography (HILIC) to capture transitions for carbon and nitrogen incorporation into selected metabolites using a hybrid triple quadrupole (QQQ) mass spectrometer. This protocol represents an extension of a previously published protocol for targeted metabolomics of unlabeled species and has been used extensively in tracing the metabolism of nutrients such as 13 C-labeled glucose, 13 C-glutamine and 15 N-glutamine in a variety of biological settings (e.g., cell culture experiments and in vivo mouse labelling via i.p. injection). SRM signals are integrated to produce an array of peak areas for each labelling form that serve as the output for further analysis. The processed data are then used to obtain the degree and distribution of labelling of the targeted molecules (termed fluxomics). Each method can be customized on the basis of known unlabeled Q1/Q3 SRM transitions and adjusted to account for the corresponding 13 C or 15 N incorporation. The entire procedure takes ~6–7 h for a single sample from experimental labelling and metabolite extraction to peak integration.

Original languageEnglish (US)
Pages (from-to)313-330
Number of pages18
JournalNature Protocols
Volume14
Issue number2
DOIs
StatePublished - Feb 1 2019

Funding

This research was supported by grants from the National Institutes of Health (5P01CA120964 to J.M.A. and B.D.M.; 5R35CA197459 to B.D.M. and J.M.A.; and 5P30CA006516 to J.M.A.) and the BIDMC Research Capital Fund for funding the mass spectrometry instrumentation. C.A.L. was supported by a Pancreatic Cancer Action Network/AACR Pathway to Leadership award (13-70-25-LYSS), a Dale F. Frey Award for Breakthrough Scientists from the Damon Runyon Cancer Research Foundation (DFS-09-14), a Junior Scholar Award from The V Foundation for Cancer Research (V2016-009), a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-16-005), and a 2017 AACR NextGen Grant for Transformative Cancer Research (17-20-01-LYSS). D.M.K was supported by a University of Michigan Program in Chemical Biology Graduate Assistance in Areas of National Need (GAANN) award. We thank L.C. Cantley (Weill-Cornell MC) and G.M. Wulf (BIDMC/HMS) for helpful discussions and the donation of K14 cells.

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC–MS/MS'. Together they form a unique fingerprint.

Cite this